Chongqing Kanghua Zhonglian Cardiovascular Hospital

Hospital Introduction: Chongqing Kanghua Zhonglian Cardiovascular Hospital (hereinafter referred to as "Chongqing Kangxin Hospital") is an investment promotion project of the "Chongqing Investment and Trade Fair" and is the first cardiovascular hospital in Chongqing. Chongqing Kangxin Hospital has 505 authorized beds, with a total investment of approximately 1 billion RMB and a building area of approximately 100,000 square meters. It is fully managed by Guangdong Kanghua Healthcare Co., Ltd. (Stock Code: HK3689).
Since its opening on March 1, 2017, Chongqing Kangxin Hospital has carried out surgical and medical treatments for diseases such as congenital heart disease, coronary heart disease, rheumatic heart disease, arrhythmia, structural heart disease, and aortic dissection. The technical backbone is mainly composed of doctors from the former Chongqing Xinqiao Hospital, the General Hospital of Shenyang Military Region, and other military and civilian institutions. The cardiovascular medical and surgical technical backbone of Xinqiao Hospital provides year-round technical support for our hospital. The equipment has reached international advanced levels, and the environment is beautiful with considerate service. As of December 31, 2017, a total of 144 cardiology surgeries and 48 cardiac surgeries have been completed.
On February 25, 2018, the "National Clinical Research Center for Cardiovascular Diseases Chongqing Kangxin Branch," "Heart Alliance Southwest Heart Center," and "Heart Alliance Southwest Atrial Fibrillation Center" were officially established in our hospital. Chongqing Kangxin Hospital adheres to the mission of "For the people, with great virtue in medicine," upholds the direction of "serving patients and serving the medical frontline," and advocates the philosophy of "excellent medical quality, convenient medical services, conscious social responsibility, and sustainable development vision," providing high-quality medical services for the people of Chongqing.